Andelyn Biosciences

Stay ahead of the curve in the evolving world of cell and gene therapies with insights from Andelyn Biosciences! Our newsletter is packed with industry updates, expert discussions, and exclusive content. Are you navigating the complexities of plasmid DNA for cell and gene therapy development? In our latest edition, we explore critical factors, from plasmid grade considerations to design optimization in our featured white paper, "Plasmid Optimization for Long-Term Commercial Success," Discover: • The distinctions between research, clinical, and commercial-grade plasmids—and what they mean for your bottom line. • Strategies to streamline manufacturing by understanding plasmid quality standards and regulatory expectations. • Key design considerations to avoid costly production issues and enable sustainable scaling for commercial success. Sign up for our newsletter today to stay up to date on these critical discussions and more: https://buff.ly/3ZRv6zl #AndelynBiosciences #PlasmidOptimization #GeneTherapy #Biopharma #CellAndGeneTherapy #ManufacturingExcellence #Newsletter

In an industry where change is ever constant, Andelyn Biosciences stands as your steadfast partner in gene therapy manufacturing. With over two decades of experience and expertise, our commitment to growth and innovation ensures we're here for you, ready to bring your groundbreaking therapies from the lab to the patient. See what a feasibility study and yield assessment can do to get your program started on a path to process industrialization: https://buff.ly/3UzqzNP #andelynbiosciences

We’re here at ESGCT 2024 at booth # B02! Join us in the poster hall to talk about our latest research: Potential Biases When Quantifying Residual Host Cell DNA: An 18S rRNA Problem. #AndelynBiosciences #ESGCT2024 #AAVCuratorPlatform #GeneTherapy #CDMO

Stop by Booth # B02 at ESGCT 2024 in Rome! Meet CEO Wade Macedone, Head of Analytical Development Will Fountain, and Senior Director of Business Development Vera Fialho de Araujo by booking time in the ESGCT app or by contacting us here https://lnkd.in/g6YE4kpY. #AndelynBiosciences #ESGCT2024 #AAVCuratorPlatform #GeneTherapy #CDMO

Are you in need of finding a home for the manufacturing of your AAV Program? Decades of AAV experience and production data allows us to know which process parameter and manufacturing technology levers to pull to quickly optimize your process. Through Optimization-By-Design™ we strike the right balance between yield and purity for the advancement of your program. Learn more about our feasibility studies as a first step into a partnership defined by expertise and trust: https://buff.ly/3A0hTJT #AndelynBiosciences #GeneTherapy #CDMO

Are you attending ESGCT 2024 in Rome? Stop by booth #B02 or book a meeting with us ahead of time through the ESGCT app or by contacting us here: https://buff.ly/3ZMhhCu We look forward to seeing you! #AndelynBiosciences #ESGCT2024 #AAVCuratorPlatform #GeneTherapy #CDMO

At Andelyn Biosciences, we believe in the power of experience, know-how, and precision. Our modern facilities, designed for today’s highest quality rigor, and team of seasoned scientists are at the forefront of AAV gene therapy, offering reliable expertise in process development and cGMP manufacturing. Start working with us with a small-scale feasibility study and generate the data to drive decisions for your critical roadmap to clinical and commercial manufacturing. Learn more about our feasibility study offer here https://buff.ly/3A0hTJT #AndelynBiosciences #GeneTherapy #CDMO

We're thrilled to share that Andelyn Biosciences has been selected by Hubble Therapeutics to manufacture clinical grade AAV for the treatment of Leber Congenital Amaurosis 16 (LCA16). Using our suspension AAV Curator™ Platform, we're proud to play a pivotal role in Hubble's mission to bring life-changing gene therapies to patients. LCA16, a severe retinal dystrophy caused by mutations in the KCNJ13 gene, affects vision from early childhood, progressing to blindness. This partnership marks a crucial step toward offering hope to those impacted by this devastating condition. Together, we are advancing innovation and making strides in gene therapy development for rare diseases. Read more here: https://lnkd.in/ghwYKXnF #GeneTherapy #RareDiseases #LCA16 #AAV #AndelynBiosciences #HubbleTherapeutics #Innovation #HealthcareTransformation #CellAndGeneTherapy #AAVCuratorPlatform

Stay ahead of the curve in the evolving world of cell and gene therapies with insights from Andelyn Biosciences! Our newsletter is packed with industry updates, expert discussions, and exclusive content. In our latest edition, don’t miss the featured webinar where Samir Acharya, Associate Director of Process Development, discusses upstream and downstream variables and how flexibility in the AAV Curator™ Platform addresses these issues in practical application. Sign up for our newsletter today to stay up to date on these critical discussions and more: https://buff.ly/3ZRv6zl #CellAndGeneTherapy #AAV #GeneTherapy #Biotech #Pharma #Quality #ProcessDevelopment #Webinar #AndelynBiosciences

Visit us at Booth # F26 during the Meeting on the Mesa conference. Meet our CEO Wade Macedone, Chief Commercial Officer Matt Niloff, and Senior Director of Business Development Joshua K. to talk about your cell and gene therapy concept-to-commercialization needs. Book a meeting with us through the Meeting on the Mesa conference app or contact us directly: https://lnkd.in/g6YE4kpY We look forward to seeing you! #AndelynBiosciences #CGMesa24 #AAVCuratorPlatform #GeneTherapy #CDMO